NAB2-STAT6 gene fusion was confirmed by RNA-based next-generation sequencing (NGS), and KRAS gene mutation was identified by DNA-based NGS, which has not been previously reported in SFT and may be associated with its malignant morphology. This evidence concerns the gene NAB2 and solitary fibrous tumor.